Neuropsychopharmacology
- The sodium leak channel NALCN in Drd2+ striatal neurons regulates neuronal excitability, locomotion and food-seeking in a sex-dependent manner7 months ago
- Galanin receptor 1 expressing neurons in hippocampal-prefrontal circuitry modulate goal directed attention and impulse control7 months ago
- Serotonin-endocannabinoid crosstalk selectively regulates inhibitory GABAergic inputs in the medial prefrontal cortex7 months ago
- Caffeine reverses sleep deprivation-induced synaptic and social memory deficits via adenosine receptor modulation in the male mouse hippocampal CA2 region7 months ago
- Characterization of a novel female chronic social defeat stress (femCSDS) model utilizing persistently aggressive CD1 parous females7 months ago
- Moderators of treatment response in late-life depression7 months ago
- Neuropsychiatric illness in the later years of life: summary and synthesis7 months ago
Journal of Psychopharmacology
- Ayahuasca-inspired DMT/harmine formulation alters creative thinking dynamics during artistic creation1 year ago
- Subjectively reported sleep improvement with antipsychotic medications in clinical practice: A systematic review, meta-analysis and meta-regression of moderating factors1 year ago
- Randomised controlled trial of clozapine in resistant schizophrenia and schizoaffective disorder1 year ago
- “Modulatory role of baseline impulsivity on the acute and persistent effects of CB1 agonism on impulsive choice”1 year ago
- Boosting the ventrolateral periaqueductal gray-ventral tegmental area pathway by disinhibition of group II mGluRs alleviates chronic restraint stress-induced depression-like behavior in mice1 year ago
- KarXT combines the partial benefits of haloperidol for positive symptoms and sulpiride for negative symptoms: Evidence from computational biology1 year ago
- High-frequency oscillations in the mammalian brain after ketamine and other NMDA receptor antagonists1 year ago
European Neuropsychopharmacology
- Efficacy, safety, and tolerability of JNJ-61393215 (tebideutorexant), a selective orexin-1 receptor antagonist, as adjunctive treatment for major depressive disorder with anxious distress: A double-blind, placebo-controlled, randomized phase 2a study1 year ago
- Supporting the call for clinical trials assessing physical exercise and creatine in depression: a response to “Muscle and the mind: The combination of creatine and exercise for depression?”1 year ago
- Longitudinal brain age in first-episode mania youth treated with lithium or quetiapine1 year ago
- Egr2 Modulation in the Medial Prefrontal Cortex Regulates Resistance to Stress-Induced Memory Impairments1 year ago
- Racial and ethnic diversity in zuranolone and brexanolone clinical trials for postpartum depression: A cross-sectional analysis of ClinicalTrials.gov1 year ago
- Creatine as a treatment for depression: A brain bioenergetics perspective1 year ago
- Rethinking suicide prediction: From static risk factors to dynamic models1 year ago